Scout | Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

This opportunity is no longer accepting applications.

grant

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

The National Cancer Institute (NCI) is offering funding for investigator-initiated clinical trials aimed at reducing cancer burden. These trials should focus on improving areas such as early detection, screening, prevention, healthcare delivery, quality of life, or survivorship, and should have the potential to enhance clinical practice or public health. Eligible studies must align with the NI…

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Program: SBIR

Dates

Opportunity Released: December 15, 2023

Open for Submission: December 15, 2023

Submission Deadline: January 7, 2027

Application Window Closes: January 7, 2027

Keywords

cancer prevention

early detection

clinical trials

healthcare delivery

quality of life

cancer survivorship

investigator-initiated studies

cancer screening

public health improvement

cancer interception

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers